High-flow needle sets are the form of needle sets designed specifically to ensure the safety and comfort of users. These high-flow needles are utilized when there are more viscous drugs need to administer into the body. Moreover, it enables faster flow and smothers the insertion of drugs. High flow needles reduce the pain and provide greater comfort than traditional needles. The proper tubing length and smaller gauge have been designed to keep the residual volume of the needle to a minimum, thus reducing drug losses and costs. Additional benefits of high flow needles are less reaction at the site, less pain and less damage to tissue, less inflammation, and less leakage. The latest high-flow needle sets consisting of cap, closure, and wings. Global high flow needle sets are normally used for the animals, but progress in pump technology opened the door to high flow sets to enter into the diabetic treatment. Currently, people who have diabetes giving the first preference to the high flow needle sets.
COVID-19 Impact Analysis
- COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
- There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the global high flow needle sets market.
Top Impacting Factors
Increase in prevalence of diabetes acts as one of the major factors driving the growth of the market.
Rise in prevalence of chronic diseases globally such as cancer, intravenous therapy, cardiovascular diseases, and bleeding disorders also help to boost the market growth.
In addition, the need for managing long-term medications and drug infusions are some of the other factors that are expected to propel market growth.
Rise in geriatric population, improvements in healthcare infrastructure, surge in healthcare expenditure, and introduction of the novel drug delivery system especially in the case of parenteral drugs may help to boost the growth of the market.
Moreover, safety and convenience provided by these needles and treatments associated with high flow needle sets, the market is expected to grow compared to substitute products.
However, a low adaptation of the global high flow needle sets and underdeveloped diagnostic centers and hospitals may hamper the growth of the global high flow needle sets market.
Market Trends
New Product Launches to Flourish the Market
- In April 2019, RMS medical products received FDA 510(k) clearance for high-flo super26 subcutaneous needle sets which allows subcutaneous infusion of medications in the home, hospital, or ambulatory settings to facilitate high flow rates.
- In 2018, Medline Industries, Inc. (U.S.) acquired Centurion Medical Products (U.S.) to enhance its prenatal kits segment and complement its minor procedure tray kits and its growing infection prevention focus.
Key Benefits of the Report
- This study presents the analytical depiction of the global high flow needle sets market industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share.
- The current market is quantitatively analyzed to highlight the market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.
Questions Answered in the Global High Flow Needle Sets Market Report
- Which are the leading market players active in the global high flow needle sets market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities of the market?
- What future projections would help in taking further strategic steps?
- What is global high flow needle sets market?
- What is global high flow needle sets market prediction in the future?
- Who are the leading global players in the global high flow needle sets market?
- What are the current trends and predicted trends?
- What are the key benefits of the global high flow needle sets market report?
Key Market Segments
- By Volume Capacity
- Less than 10ml
- 10-100ml
- More than 100ml
- By Raw Material
- Stainless Steel
- Polycarbonate
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Center
- Others
- By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Thermo Fisher Scientific Inc.
- TradeMed, BD.
- Medline Industries, Inc.
- Norfolk Medical
- MEDIWIDE SDN BHD
- B. Braun Melsungen AG
- Right Way Medical
- IMD INC
- Amdel
- KORU Medical Systems
- Concordance Healthcare Solutions
- George Philips
- Wolf-Pak
- Smiths Group plc